Literature DB >> 19935662

Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.

Steven A McCarroll1, James E Bradner, Hannu Turpeinen, Liisa Volin, Paul J Martin, Shannon D Chilewski, Joseph H Antin, Stephanie J Lee, Tapani Ruutu, Barry Storer, Edus H Warren, Bo Zhang, Lue Ping Zhao, David Ginsburg, Robert J Soiffer, Jukka Partanen, John A Hansen, Jerome Ritz, Aarno Palotie, David Altshuler.   

Abstract

Transplantation and pregnancy, in which two diploid genomes reside in one body, can each lead to diseases in which immune cells from one individual target antigens encoded in the other's genome. One such disease, graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT, or bone marrow transplant), is common even after transplants between HLA-identical siblings, indicating that cryptic histocompatibility loci exist outside the HLA locus. The immune system of an individual whose genome is homozygous for a gene deletion could recognize epitopes encoded by that gene as alloantigens. Analyzing common gene deletions in three HSCT cohorts (1,345 HLA-identical sibling donor-recipient pairs), we found that risk of acute GVHD was greater (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.4-4.6) when donor and recipient were mismatched for homozygous deletion of UGT2B17, a gene expressed in GVHD-affected tissues and giving rise to multiple histocompatibility antigens. Human genome structural variation merits investigation as a potential mechanism in diseases of alloimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19935662      PMCID: PMC2804745          DOI: 10.1038/ng.490

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  32 in total

1.  The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes.

Authors:  Helen Skaletsky; Tomoko Kuroda-Kawaguchi; Patrick J Minx; Holland S Cordum; LaDeana Hillier; Laura G Brown; Sjoerd Repping; Tatyana Pyntikova; Johar Ali; Tamberlyn Bieri; Asif Chinwalla; Andrew Delehaunty; Kim Delehaunty; Hui Du; Ginger Fewell; Lucinda Fulton; Robert Fulton; Tina Graves; Shun-Fang Hou; Philip Latrielle; Shawn Leonard; Elaine Mardis; Rachel Maupin; John McPherson; Tracie Miner; William Nash; Christine Nguyen; Philip Ozersky; Kymberlie Pepin; Susan Rock; Tracy Rohlfing; Kelsi Scott; Brian Schultz; Cindy Strong; Aye Tin-Wollam; Shiaw-Pyng Yang; Robert H Waterston; Richard K Wilson; Steve Rozen; David C Page
Journal:  Nature       Date:  2003-06-19       Impact factor: 49.962

2.  HapMap scanning of novel human minor histocompatibility antigens.

Authors:  Michi Kamei; Yasuhito Nannya; Hiroki Torikai; Takakazu Kawase; Kenjiro Taura; Yoshihiro Inamoto; Taro Takahashi; Makoto Yazaki; Satoko Morishima; Kunio Tsujimura; Koichi Miyamura; Tetsuya Ito; Hajime Togari; Stanley R Riddell; Yoshihisa Kodera; Yasuo Morishima; Toshitada Takahashi; Kiyotaka Kuzushima; Seishi Ogawa; Yoshiki Akatsuka
Journal:  Blood       Date:  2008-09-22       Impact factor: 22.113

3.  Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation.

Authors:  I Aguilera; I Wichmann; J M Sousa; A Bernardos; E Franco; J R García-Lozano; A Núñez-Roldán
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

Authors:  E H Warren; M A Gavin; E Simpson; P Chandler; D C Page; C Disteche; K A Stankey; P D Greenberg; S R Riddell
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

Authors:  Mario H J Vogt; Joost W van den Muijsenberg; Els Goulmy; Eric Spierings; Petra Kluck; Michel G Kester; Ronald A van Soest; Jan W Drijfhout; Roel Willemze; J H Frederik Falkenburg
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

6.  Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Authors:  David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

7.  Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

Authors:  Sophia S B Randolph; Theodore A Gooley; Edus H Warren; Frederick R Appelbaum; Stanley R Riddell
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

8.  Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation.

Authors:  Eric Spierings; Corine J Vermeulen; Mario H Vogt; Lucie E E Doerner; J H Frederik Falkenburg; Tuna Mutis; Els Goulmy
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

9.  Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation.

Authors:  Emmanuel Zorn; David B Miklos; Blair H Floyd; Alex Mattes-Ritz; Luxuan Guo; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  J Exp Med       Date:  2004-04-19       Impact factor: 14.307

10.  A human minor histocompatibility antigen resulting from differential expression due to a gene deletion.

Authors:  Makoto Murata; Edus H Warren; Stanley R Riddell
Journal:  J Exp Med       Date:  2003-05-12       Impact factor: 14.307

View more
  45 in total

1.  SNPs and prognosis of GvHD before HCT: any progress?

Authors:  M I Abu Zaid; S Paczesny; D B Miklos
Journal:  Bone Marrow Transplant       Date:  2015-10-12       Impact factor: 5.483

Review 2.  Non-HLA donor-recipient mismatches in kidney transplantation-A stone left unturned.

Authors:  Samira Farouk; Zhongyang Zhang; Madhav C Menon
Journal:  Am J Transplant       Date:  2019-10-19       Impact factor: 8.086

3.  Copy number variation and antigenic repertoire.

Authors:  John A L Armour
Journal:  Nat Genet       Date:  2009-12       Impact factor: 38.330

Review 4.  Transplant genetics and genomics.

Authors:  Joshua Y C Yang; Minnie M Sarwal
Journal:  Nat Rev Genet       Date:  2017-03-13       Impact factor: 53.242

5.  Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens.

Authors:  Jefferson L Lansford; Udara Dharmasiri; Shengjie Chai; Sally A Hunsucker; Dante S Bortone; James E Keating; Ian M Schlup; Gary L Glish; Edward J Collins; Gheath Alatrash; Jeffrey J Molldrem; Paul M Armistead; Benjamin G Vincent
Journal:  Blood Adv       Date:  2018-08-28

Review 6.  Phenotypic impact of genomic structural variation: insights from and for human disease.

Authors:  Joachim Weischenfeldt; Orsolya Symmons; François Spitz; Jan O Korbel
Journal:  Nat Rev Genet       Date:  2013-02       Impact factor: 53.242

Review 7.  Applying genomics in heart transplantation.

Authors:  Brendan J Keating; Alexandre C Pereira; Michael Snyder; Brian D Piening
Journal:  Transpl Int       Date:  2018-02-12       Impact factor: 3.782

8.  Joint testing of donor and recipient genetic matching scores and recipient genotype has robust power for finding genes associated with transplant outcomes.

Authors:  Victoria L Arthur; Weihua Guan; Bao-Li Loza; Brendan Keating; Jinbo Chen
Journal:  Genet Epidemiol       Date:  2020-08-11       Impact factor: 2.135

9.  Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.

Authors:  Paul J Martin; David M Levine; Barry E Storer; Edus H Warren; Xiuwen Zheng; Sarah C Nelson; Anajane G Smith; Bo K Mortensen; John A Hansen
Journal:  Blood       Date:  2016-11-21       Impact factor: 22.113

10.  Monozygotic twins with GATA2 deficiency: same haploidentical-related donor, different severity of GvHD.

Authors:  N N Shah; M Parta; K Baird; H Rafei; K Cole; S M Holland; D D Hickstein
Journal:  Bone Marrow Transplant       Date:  2017-08-21       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.